Indication
stage iv merkel cell carcinoma
2 clinical trials
2 drugs
Clinical trial
A Phase II Study of MK-3475 in Patients With Advanced Merkel Cell Carcinoma (MCC)Status: Completed, Estimated PCD: 2018-02-06
Drug
mFOLFOX6Clinical trial
A Phase II, Single-Arm Open-Label Study of the Combination of Atezolizumab and Bevacizumab in Rare Solid TumorsStatus: Active (not recruiting), Estimated PCD: 2025-09-30
Drug
Atezolizumab